P-Chlorophenylalanine, a Serotonin Synthesis Inhibitor, Reduces the Response of Glial Fibrillary Acidic Protein Induced by Trauma to the Spinal Cord. An Immunohistochemical Investigation in the Rat

Overview

Journal Acta Neuropathol

Specialty Neurology

Date 1993 Jan 1

PMID 8310791

Citations 9

Authors

H S Sharma

Y Olsson

J Cervos-Navarro

Affiliations

Soon will be listed here.

Abstract

The possibility that serotonin may influence the early response of astrocytes around a spinal cord trauma was investigated in a rat model by making a unilateral incision into the right dorsal horn of the T10-11 segments. One group of rats received a serotonin synthesis inhibitor, p-chlorophenylalanine (p-CPA) before injury in doses which cause a depletion of serotonin in the cord. Another group of traumatised rats did not receive p-CPA. All animals were allowed to survive for 5 h. Samples for immunohistochemistry were taken from the T9, T10-11 and T12 segments of the cord. Paraffin sections were immunostained for glial fibrillary acidic protein (GFAP) using monoclonal antibodies and avidin-biotin complex technique. Trauma to the cord resulted in a marked increase of GFAP immunoreactivity in all the investigated segments, particularly in the ipsilateral side. Pretreatment with p-CPA markedly reduced the GFAP response. This drug did not by itself influence the GFAP immunoreactivity of the cord of untraumatised rats. Our results show that trauma to the spinal cord induces a rapid enhancement of GFAP immunoreactivity in the cord which is present even far away from the primary lesion. This response can be prevented by pretreatment with the serotonin synthesis inhibitor, p-CPA. The results indicate that serotonin influences the increase of GFAP immunoreactivity following spinal cord injury either directly or indirectly, for instance by its microvascular reactions.

Citing Articles

Motor Cortex Stimulation Reversed Hypernociception, Increased Serotonin in Raphe Neurons, and Caused Inhibition of Spinal Astrocytes in a Parkinson's Disease Rat Model.

Campos A, Berzuino M, Barbosa G, Freire H, Lopes P, Assis D Cells. 2021; 10(5).

PMID: 34064617 PMC: 8150310. DOI: 10.3390/cells10051158.

Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Lafuente J, Sharma A, Muresanu D, Ozkizilcik A, Tian Z, Patnaik R Mol Neurobiol. 2017; 55(1):322-334.

PMID: 28861718 DOI: 10.1007/s12035-017-0744-7.

Exacerbation of Methamphetamine Neurotoxicity in Cold and Hot Environments: Neuroprotective Effects of an Antioxidant Compound H-290/51.

Sharma H, Kiyatkin E, Patnaik R, Lafuente J, Muresanu D, Sjoquist P Mol Neurobiol. 2015; 52(2):1023-33.

PMID: 26111626 PMC: 5518775. DOI: 10.1007/s12035-015-9252-9.

Cardiac Arrest Alters Regional Ubiquitin Levels in Association with the Blood-Brain Barrier Breakdown and Neuronal Damages in the Porcine Brain.

Sharma H, Patnaik R, Sharma A, Lafuente J, Miclescu A, Wiklund L Mol Neurobiol. 2015; 52(2):1043-53.

PMID: 26108181 DOI: 10.1007/s12035-015-9254-7.

Not just the brain: methamphetamine disrupts blood-spinal cord barrier and induces acute glial activation and structural damage of spinal cord cells.

Kiyatkin E, Sharma H CNS Neurol Disord Drug Targets. 2015; 14(2):282-94.

PMID: 25687701 PMC: 4530622. DOI: 10.2174/1871527314666150217121354.

References

Cancilla P, Bready J, Berliner J, Toga A, Santori E, Scully S . Expression of mRNA for glial fibrillary acidic protein after experimental cerebral injury. J Neuropathol Exp Neurol. 1992; 51(5):560-5. DOI: 10.1097/00005072-199209000-00011. View

Morrison R, de Vellis J, Lee Y, Bradshaw R, Eng L . Hormones and growth factors induce the synthesis of glial fibrillary acidic protein in rat brain astrocytes. J Neurosci Res. 1985; 14(2):167-76. DOI: 10.1002/jnr.490140202. View

Tao-Cheng J, Brightman M . Development of membrane interactions between brain endothelial cells and astrocytes in vitro. Int J Dev Neurosci. 1988; 6(1):25-37. DOI: 10.1016/0736-5748(88)90026-3. View

Bernstein J, Goldberg W . Injury-related spinal cord astrocytes are immunoglobulin-positive (IgM and/or IgG) at different time periods in the regenerative process. Brain Res. 1987; 426(1):112-8. DOI: 10.1016/0006-8993(87)90430-6. View

Chiu F, Goldman J . Regulation of glial fibrillary acidic protein (GFAP) expression in CNS development and in pathological states. J Neuroimmunol. 1985; 8(4-6):283-92. DOI: 10.1016/s0165-5728(85)80067-9. View

Graeber M, Kreutzberg G . Astrocytes increase in glial fibrillary acidic protein during retrograde changes of facial motor neurons. J Neurocytol. 1986; 15(3):363-73. DOI: 10.1007/BF01611438. View

Goldman J . Astrocytes regulate GFAP mRNA levels by cyclic AMP and protein kinase C-dependent mechanisms. Glia. 1988; 1(5):346-54. DOI: 10.1002/glia.440010507. View

Schmidt-Kastner R, Freund T . Selective vulnerability of the hippocampus in brain ischemia. Neuroscience. 1991; 40(3):599-636. DOI: 10.1016/0306-4522(91)90001-5. View

Nieto-Sampedro M . Astrocyte mitogen inhibitor related to epidermal growth factor receptor. Science. 1988; 240(4860):1784-6. DOI: 10.1126/science.3289118. View

10.

Eng L . Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol. 1985; 8(4-6):203-14. DOI: 10.1016/s0165-5728(85)80063-1. View

11.

Nieto-Sampedro M, Broderick J . A soluble brain molecule related to epidermal growth factor receptor is a mitogen inhibitor for astrocytes. J Neurosci Res. 1989; 22(1):28-35. DOI: 10.1002/jnr.490220105. View

12.

Condorelli D, DellAlbani P, Kaczmarek L, Messina L, Spampinato G, Avola R . Glial fibrillary acidic protein messenger RNA and glutamine synthetase activity after nervous system injury. J Neurosci Res. 1990; 26(2):251-7. DOI: 10.1002/jnr.490260216. View

13.

Sharma H, Olsson Y, Dey P . Changes in blood-brain barrier and cerebral blood flow following elevation of circulating serotonin level in anesthetized rats. Brain Res. 1990; 517(1-2):215-23. DOI: 10.1016/0006-8993(90)91029-g. View

14.

Olsson Y, Sharma H, Pettersson C . Effects of p-chlorophenylalanine on microvascular permeability changes in spinal cord trauma. An experimental study in the rat using 131I-sodium and lanthanum tracers. Acta Neuropathol. 1990; 79(6):595-603. DOI: 10.1007/BF00294236. View

15.

Hajos F, Kalman M . Distribution of glial fibrillary acidic protein (GFAP)-immunoreactive astrocytes in the rat brain. II. Mesencephalon, rhombencephalon and spinal cord. Exp Brain Res. 1989; 78(1):164-73. DOI: 10.1007/BF00230695. View

16.

Murphy S, Pearce B . Functional receptors for neurotransmitters on astroglial cells. Neuroscience. 1987; 22(2):381-94. DOI: 10.1016/0306-4522(87)90342-3. View

17.

Goldman J, Abramson B . Cyclic AMP-induced shape changes of astrocytes are accompanied by rapid depolymerization of actin. Brain Res. 1990; 528(2):189-96. DOI: 10.1016/0006-8993(90)91657-3. View

18.

Zimmer C, Sampaolo S, Sharma H, Cervos-Navarro J . Altered glial fibrillary acidic protein immunoreactivity in rat brain following chronic hypoxia. Neuroscience. 1991; 40(2):353-61. DOI: 10.1016/0306-4522(91)90125-8. View

19.

Aquino D, Chiu F, Brosnan C, Norton W . Glial fibrillary acidic protein increases in the spinal cord of Lewis rats with acute experimental autoimmune encephalomyelitis. J Neurochem. 1988; 51(4):1085-96. DOI: 10.1111/j.1471-4159.1988.tb03072.x. View

20.

Petito C, Morgello S, Felix J, Lesser M . The two patterns of reactive astrocytosis in postischemic rat brain. J Cereb Blood Flow Metab. 1990; 10(6):850-9. DOI: 10.1038/jcbfm.1990.141. View